The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Dysport 500 units Powder for solution for injection

Ipsen PharmaPA1613/002/001

Main Information

Trade NameDysport 500 units Powder for solution for injection
Active SubstancesClostridium botulinum toxin type a haemagglutinin complex
Dosage FormPowder for solution for injection
Licence HolderIpsen Pharma
Licence NumberPA1613/002/001

Group Information

ATC CodeJ06AA Immune sera
J06AA04 botulinum antitoxin


License statusAuthorised
Licence Issued20/04/1994
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back